The Global Antibiotic Research and Development Partnership (GARDP) is a not-for-profit organization that develops new antibiotic treatments for drug-resistant bacterial infections that pose the greatest threat to human health, and makes them accessible to the people who need them. It puts public health needs at the centre of antibiotic drug development to address both the immediate antimicrobial resistance (AMR) crisis and to ensure people continue to get access to essential antibiotics for generations to come. 

GARDP was created by WHO and DNDi to deliver on the Global Action Plan on AMR (2015), which underscores the need for new initiatives to develop novel antibiotic treatments. Legally established as an independent foundation in Geneva, Switzerland in 2018, GARDP responds to the urgent need for antibiotic research, development and access.